Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VENTURE LIFE GROUP PLC Director's Dealing 2016

Jun 14, 2016

8004_dirs_2016-06-14_e90fbd85-8f24-40cb-861e-828979ad67e4.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1559B

Venture Life Group PLC

14 June 2016

Venture Life Group PLC

("Venture Life" or the "Company")

Director/PDMR Shareholding

Bracknell, UK - 14 June 2016: Venture Life Group plc (AIM: VLG), the international consumer healthcare group addressing the self-care needs of the ageing population, announces that it was informed on 13 June 2016 that Ms. Sharon Collins, the Commercial Director of the Company, has undertaken dealings in 27,030 ordinary shares of 0.3p each in the Company ("Ordinary Shares"), transferring 26,430 of her current holding of Ordinary Shares to her ISA, and selling and re-purchasing 600 Ordinary Shares to be held in her non-ISA account.

The dealings were made between 8 June 2016 and 13 June 2016 as set out below:

Date Dealing type Number of Ordinary Shares sold Number of Ordinary Shares purchased Price (p)
8 June 2016 Sale 26,600 - 57.00
8 June 2016 Purchased to ISA - 26,000 57.10
9 June 2016 Sale 430 - 57.00
9 June 2016 Purchased to ISA - 430 57.00
Total sold 27,030 -
Total purchased to ISA - 26,430
13 June 2016 Purchase - 600 59.49
Total dealings 27,030 27,030

Following the dealings, Ms. Collins's beneficial interest in the Company remains unchanged at 1,582,417 Ordinary Shares, representing approximately 4.3% of the issued share capital in the Company.

For further information please contact:

Venture Life Group PLC

Jerry Randall, Chief Executive Officer                                                    +44 (0)1344 742 870

James Hunter, Chief Financial Officer                                                   

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)                             

Freddy Crossley                                                                                                               +44 (0) 20 7886 2500

Peter Steel

Duncan Monteith                                                                                                           

Corporate Finance

Tom Salvesen

Corporate Broking                                                                                                          

Square1 Consulting

David Bick

Brian Alexander                                                                                                               +44 (0)20 7929 5599

About Venture Life

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.

The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFLLRDISLIR